Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
$0.29
+15.4%
$0.25
$0.12
$2.93
$13.52M0.0713.48 million shs5.84 million shs
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
$1.38
+2.2%
$1.50
$1.21
$4.22
$50.48M-0.0969,649 shs46,293 shs
PolyPid Ltd. stock logo
PYPD
PolyPid
$3.50
+0.6%
$3.50
$2.30
$3.93
$55.64M1.464,468 shs54,985 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.25
-0.6%
$4.51
$3.03
$9.33
$53.43M1.34218,419 shs182,294 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
0.00%+19.26%-1.89%+22.22%-89.69%
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
0.00%+1.47%-3.50%-22.03%-67.14%
PolyPid Ltd. stock logo
PYPD
PolyPid
0.00%+1.45%-6.42%+25.94%-0.85%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%-2.99%-42.48%-30.70%-53.57%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
0.2718 of 5 stars
0.03.00.00.00.61.70.0
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
2.9878 of 5 stars
3.25.00.00.02.21.70.6
PolyPid Ltd. stock logo
PYPD
PolyPid
2.6388 of 5 stars
3.65.00.00.01.01.70.0
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
1.917 of 5 stars
3.51.00.00.02.91.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
0.00
N/AN/AN/A
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
2.33
Hold$8.50515.94% Upside
PolyPid Ltd. stock logo
PYPD
PolyPid
3.17
Buy$12.40254.29% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.00
Buy$8.00146.15% Upside

Current Analyst Ratings Breakdown

Latest DHAI, PYPD, EDAP, and SRTS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/14/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$15.00 ➝ $13.00
8/14/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
8/13/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$13.00
8/12/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$12.00 ➝ $8.00
8/8/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$13.00 ➝ $6.00
6/18/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$12.00 ➝ $9.00
6/17/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$16.00 ➝ $14.00
6/9/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$11.00 ➝ $13.00
6/5/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$9.00
6/2/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeBuy$11.00
(Data available from 8/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
$64.47M0.21N/AN/A($0.80) per share-0.36
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
$69.18M0.75N/AN/A$1.18 per share1.17
PolyPid Ltd. stock logo
PYPD
PolyPid
N/AN/AN/AN/A$0.75 per shareN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.28$0.43 per share7.52$3.41 per share0.95
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
-$8.44M-$0.300.00N/A-13.59%N/A-25.97%N/A
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
-$20.58M-$0.62N/AN/AN/A-34.45%-51.42%-26.43%8/28/2025 (Estimated)
PolyPid Ltd. stock logo
PYPD
PolyPid
-$29.02M-$3.830.00N/AN/A-453.95%-138.92%11/12/2025 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M-$0.060.0014.13N/A-2.26%-1.58%-1.41%N/A

Latest DHAI, PYPD, EDAP, and SRTS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/28/2025Q2 2025
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
-$0.18N/AN/AN/A$16.60 millionN/A
8/13/2025Q2 2025
PolyPid Ltd. stock logo
PYPD
PolyPid
-$0.53-$0.78-$0.25-$0.78N/AN/A
8/7/2025Q2 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.01-$0.06-$0.07-$0.06$9.30 million$7.32 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
N/AN/AN/AN/AN/A
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
N/AN/AN/AN/AN/A
PolyPid Ltd. stock logo
PYPD
PolyPid
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
N/A
0.51
0.34
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
0.10
1.74
1.21
PolyPid Ltd. stock logo
PYPD
PolyPid
N/A
2.28
2.28
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.14
5.79

Institutional Ownership

CompanyInstitutional Ownership
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
27.76%
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
62.74%
PolyPid Ltd. stock logo
PYPD
PolyPid
26.47%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
49.58%
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
0.23%
PolyPid Ltd. stock logo
PYPD
PolyPid
24.70%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
N/A47.34 million23.87 millionN/A
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
23037.39 million37.31 millionOptionable
PolyPid Ltd. stock logo
PYPD
PolyPid
8015.90 million11.97 millionNo Data
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable

Recent News About These Companies

Sensus Healthcare (SRTS) Receives a Buy from Roth MKM
Sensus (SRTS) Q2 Revenue Falls 21%

New MarketBeat Followers Over Time

Media Sentiment Over Time

DIH Holding US stock logo

DIH Holding US NASDAQ:DHAI

$0.29 +0.04 (+15.35%)
Closing price 08/22/2025 03:59 PM Eastern
Extended Trading
$0.27 -0.01 (-5.08%)
As of 08/22/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.

EDAP TMS stock logo

EDAP TMS NASDAQ:EDAP

$1.38 +0.03 (+2.22%)
Closing price 08/22/2025 03:30 PM Eastern
Extended Trading
$1.38 0.00 (0.00%)
As of 08/22/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.

PolyPid stock logo

PolyPid NASDAQ:PYPD

$3.50 +0.02 (+0.57%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$3.46 -0.04 (-1.11%)
As of 08/22/2025 06:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$3.25 -0.02 (-0.61%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$3.26 +0.00 (+0.15%)
As of 08/22/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.